DOI:
10.1055/s-00000005
Aktuelle Rheumatologie
LinksClose Window
References
Bello RJ. et al.
The Therapeutic Efficacy of Botulinum Toxin in Treating Scleroderma-Associated Raynaud's Phenomenon: A Randomized, Double-Blind, Placebo-Controlled Clinical Trial.
Arthritis Rheumatol 2017;
69: 1661-1669
Access:
Access:
We do not assume any responsibility for the contents of the web pages of other providers.